{"id":44484,"date":"2020-02-19T13:29:00","date_gmt":"2020-02-19T21:29:00","guid":{"rendered":"http:\/\/www.kentreporter.com\/home\/state-senate-passes-three-bills-to-curb-prescription-drug-prices\/"},"modified":"2020-02-19T13:29:00","modified_gmt":"2020-02-19T21:29:00","slug":"state-senate-passes-three-bills-to-curb-prescription-drug-prices","status":"publish","type":"post","link":"https:\/\/www.kentreporter.com\/northwest\/state-senate-passes-three-bills-to-curb-prescription-drug-prices\/","title":{"rendered":"State Senate passes three bills to curb prescription drug prices"},"content":{"rendered":"
The state Senate passed three bills sponsored by Sen. Karen Keiser, D-Des Moines, that would rein in sharply rising prescription drug prices.<\/p>\n
“Prescription drug costs are out of control,” Keiser said in a Washington State Senate Democrats news release. “Our constituents can’t wait. The taxpayers can’t wait. We have to do something about this increase in costs.”<\/p>\n
The three bills that the Senate passed on Tuesday take on insulin costs as well as costs for the most expensive prescriptions and those that are increasing in price the fastest.<\/p>\n
• SB 6087<\/a> would cap out-of-pocket cost to patients for insulin at $100 per month. It passed on a vote of 34-14.<\/p>\n